Atlantis China Healthcare USDRegister to Unlock Ratings |
Performance History | 31/03/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 18.7 | -13.1 | -11.6 | -19.2 | -7.1 | |
+/-Cat | 1.3 | -22.5 | -6.9 | -16.1 | -12.3 | |
+/-B’mrk | - | -31.3 | -17.4 | -16.6 | -15.1 | |
Category: Sector Equity Healthcare | ||||||
Category Benchmark: Morningstar Gbl Health TME ... |
Key Stats | ||
NAV 18/04/2024 | USD 1.09 | |
Day Change | -0.32% | |
Morningstar Category™ | Sector Equity Healthcare | |
ISIN | IE00B1WL3F32 | |
Fund Size (Mil) 17/04/2024 | USD 11.50 | |
Share Class Size (Mil) 17/04/2024 | USD 11.47 | |
Max Initial Charge | - | |
Ongoing Charge 09/02/2022 | 1.56% |
Investment Objective: Atlantis China Healthcare USD |
The objective of the fund is to achieve long term capital appreciation through an actively managed portfolio of equity and equity related securities issued by companies listed on recognised exchanges in Hong Kong, the People’s Republic of China, Singapore, the United States and the United Kingdom, principally engaged in pharmaceutical, bio-technology, medical devices, healthcare provision and ownership or management of hospitals/nursing homes, health maintenance organisations or in other health related industries . |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Yan Yang 01/01/2018 | ||
Inception Date 19/06/2007 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
Hang Seng HSI GR USD | Morningstar Gbl Health TME NR USD |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for Atlantis China Healthcare USD | - |
|
|
Top 5 Holdings | Sector | % |
No Data Available | ||
Increase Decrease New since last portfolio | ||
Atlantis China Healthcare USD |